摘要
用发色底物法对５种呼吸系统疾病患者及健康人作了血浆激肽释放酶（ＰＫ）的检测，结果显示：（１）肺心病组（４０例）为１３３．７％±４２．０％；（２）慢阻肺组（３０例）为１３０．８％±３２．９％；（３）哮喘组（１３例）１５５．０％±４１．７％；（４）胸腔积液组（２１例）为１１９．３％±４１．４％；（５）肺癌组（１１例）为１２７．０％±４１．７％；（６）对照组（健康人１００例）为９７．２％±２６．８％（对照组ＶＳ（１）、（２）、（３）组比Ｐ＜０．０１；对照组ＶＳ（４）、（５）纽比Ｐ＜０．０５）。对其临床意义作了讨论。
The plasma levels of the kallikrein-kinin (PK) system in five kinds of respiratory disease were determined by chromogenic substrate, the results were 133.7 % ±42%in corpulmonale (40 cases), 130.8%±32. 9%in chronic obstructive pulmonale disease (30 cases), 155. 0% ±41. 7 % in bronchial asthma(13 cases), 119. 3% ±41. 4% in pleural fluid (21 cases), 127. 0%±41. 7% in cancer of lung (11 cases),and 97. 2 % ±26. 8% in control group (100 cases ). (control group vs five kinds of respiratory diseasegroup P<0.05～P<0. 01). The results suggest that the changes of plasma levels of PK has an helpfulassessment of the condition and its prognosis of the five kinds of respiratory disease.
出处
《广东医学院学报》
1996年第3期223-224,共2页
Journal of Guangdong Medical College
关键词
呼吸系统疾病
肺心病
哮喘
血浆激肽释放酶
plasma kallikrein
pulmonary heart disease/diagnosis
chronic obstructive pulmonary disease/diagnosis
asthma/diagnosis
pleural fluid/diagnosis
lung cancer/diagnosis
